In February 2018 FDA approved some label changes for Rexulti for the addition of warnings about pathological gambling and other compulsive behaviors. Here is some of the text which was added to the Warnings and Precautions section of the Rexulti drug label: 5.7 Pathological Gambling and Other Compulsive Behaviors Post-marketing case reports … [Read more...]